THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
发明人:
Bruno DOIRON,Ralph A DEFRONZO
申请号：
US16394312
公开号：
US20190307809A1
申请日:
2019.04.25
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Embodiments of the invention stimulate three levels of beta cell physiology: (i) glucose metabolism, (ii) membrane receptor function, and (iii) transcriptional factors that result in the in vivo formation of beta cells in the pancreas for the purpose of treating diabetes.
